Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 6Completed 3Withdrawn 2Unknown 2Terminated 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 2lenvatinib 1fludarabine 1Sorafenib 1Nivolumab 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Folfox protocol 1Ethiodized Oil 1Cyclophosphamide 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Carcinoma, Hepatocellular × fludarabine × Clear all
NCT06968195 2026-04-15

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Roswell Park Cancer Institute

Phase 1 Suspended
24 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡